1100022I preclinical services for the development of interventional agents for infectious diseases. To 10: preclinical services for the development of therapeutics against antimicrobial resistant…

Ended Awarded Last action

Contract number
HHSN27200010
Awardee
Awarding agency
Obligated
$605,471

Award facts

Opportunity
  • NIHAI2010090 Solicitation number
Contract value 12% obligated
  • $605,471.00 Current, with exercised options
  • $4,866,923.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · 1100022I to change payment office due to contract transfer. Preclinical services for the development of interventional agents for infectious diseases. To 10:… $0
Original award $605,471

About this award

This is a $4,866,923.00 delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute, for preclinical services to support the development of therapeutics against antimicrobial resistant organisms. The delivery order is part of a larger program titled "Preclinical Services for the Development of Interventional Agents for Infectious Diseases." There is no set-aside designation for this award, which has a completion date of February 1, 2018. Sri International has a history of providing a range of research, development, and advisory services to federal agencies, including the Department of Defense, Department of Health and Human Services, Department of Education, and NASA, through prime and subcontract vehicles.

Description

1100022I preclinical services for the development of interventional agents for infectious diseases. To 10: preclinical services for the development of therapeutics against antimicrobial resistant organisms.

Quick answers

Who was awarded contract HHSN27200010?

HHSN27200010 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 9, 2016.

How much is contract HHSN27200010 worth?

The government has obligated $605,471 on HHSN27200010. Its potential value, with all options, is $4,866,923.

Is contract HHSN27200010 an order under another contract?

Yes. HHSN27200010 is a delivery order under HHSN272201100022I, an indefinite delivery contract.

Was contract HHSN27200010 competed?

The extent of competition for HHSN27200010 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award